Splicing molecular biology and novel therapies in diffuse malignant peritoneal mesothelioma
Sign Up to like & getrecommendations! Published in 2019 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2018.12.042
Abstract: Diffuse malignant peritoneal mesothelioma (DMPM) is a rare and the need for novel rational therapies specifically developed and valiaggressive disease arising from the peritoneum with very limited therapeutic options [1]. In about 60% of the… read more here.
Keywords: dmpm; malignant peritoneal; peritoneal mesothelioma; biology ... See more keywords
Molecular characterization of localized pleural mesothelioma
Sign Up to like & getrecommendations! Published in 2019 at "Modern Pathology"
DOI: 10.1038/s41379-019-0330-9
Abstract: Localized pleural mesothelioma is a rare solitary circumscribed pleural tumor that is microscopically similar to diffuse malignant pleural mesothelioma. However, the molecular characteristics and nosologic relationship with its diffuse counterpart remain unknown. In a consecutive… read more here.
Keywords: localized pleural; mesothelioma; pleural mesotheliomas; malignant pleural ... See more keywords
Molecular characterization of diffuse malignant peritoneal mesothelioma
Sign Up to like & getrecommendations! Published in 2020 at "Modern Pathology"
DOI: 10.1038/s41379-020-0588-y
Abstract: Malignant peritoneal mesothelioma is a rare aggressive tumor that arises from the peritoneal lining. While recurrent BAP1 mutations have been identified in a subset of mesotheliomas, molecular characteristics of peritoneal mesotheliomas, including those lacking BAP1… read more here.
Keywords: mesothelioma; bap1; malignant peritoneal; peritoneal mesothelioma ... See more keywords
Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Hyperthermia"
DOI: 10.1080/02656736.2022.2066728
Abstract: Abstract Objectives To investigate independent factors for the efficacy and safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of diffuse malignant peritoneal mesothelioma (DMPM). Methods The clinical database of 110… read more here.
Keywords: malignant peritoneal; diffuse malignant; intraperitoneal chemotherapy; plus hyperthermic ... See more keywords
A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0275187
Abstract: Background Diffuse malignant peritoneal mesothelioma (DMPM) is a rare variant of malignant mesothelioma, representing 10–15% of malignant mesothelioma cases. The preferred therapeutic approach is cytoreductive surgery (CRS) accompanied by hyperthermic intraperitoneal chemotherapy (HIPEC); the role… read more here.
Keywords: neoadjuvant chemotherapy; diffuse malignant; mesothelioma; systemic chemotherapy ... See more keywords
Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15030662
Abstract: Simple Summary Mesothelioma is a rare cancer that originates in mesothelial surfaces of the peritoneum, pleura, and other sites. Diffuse malignant peritoneal mesothelioma (DMPM) corresponds to approximately 15% of all mesotheliomas. Cytoreductive surgery and HIPEC… read more here.
Keywords: malignant peritoneal; diffuse malignant; peritoneal mesothelioma; mesothelioma ... See more keywords